Review
Nature Reviews Cancer 5, 640-648 (August 2005) | doi:10.1038/nrc1672
There is an Erratum (1 September 2005) associated with this article.
The TCL1 family of oncoproteins: co-activators of transformation
Michael A. Teitell1 About the author
Abstract
The T-cell leukaemia/lymphoma 1 (TCL1)-family oncoproteins augment AKT signal transduction and enhance cell proliferation and survival. Chromosome rearrangements, faulty developmental silencing and Epstein–Barr virus infection appear to dysregulate the expression of TCL1-family genes, provoking several important types of lymphocyte cancer. A key role for TCL1 proteins in cell transformation has been established in studies of transgenic mouse models, which develop a unique spectrum of T- and B-cell malignancies. How TCL1 proteins are regulated and dysregulated, how they promote transformation and the potential for therapies modelled on TCL1 interactions have important implications for understanding and treating lymphocyte cancers.
- View At a Glance
Author affiliations
-
Department of Pathology and Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, 675 Charles Young Drive South, 4-762 MacDonald Research Laboratories, Los Angeles, California 90095-1732, USA.
Email: mteitell@ucla.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative stateLeukemia Original Article
The Tcl1 oncogene defines secondary hair germ cells differentiation at catagen?telogen transition and affects stem-cell marker CD34 expressionOncogene Original Article
TCL1 Oncogene Expression in B Cell Subsets from Lymphoid Hyperplasia and Distinct Classes of B Cell LymphomaLaboratory Investigation Article Response
Alterations of DNA damage-response genes ATM and ATR in pyothorax-associated lymphomaLaboratory Investigation Research Article
See all 6 matches for Research